Use of intravitreous bevacizumab to treat macular edema in West Nile virus chorioretinitis

Arch Ophthalmol. 2012 Mar;130(3):396-8. doi: 10.1001/archopthalmol.2011.1630.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Angiogenesis Inhibitors / administration & dosage*
  • Antibodies, Monoclonal, Humanized / administration & dosage*
  • Bevacizumab
  • Chorioretinitis / drug therapy*
  • Chorioretinitis / pathology
  • Chorioretinitis / virology
  • Humans
  • Intravitreal Injections
  • Macular Edema / drug therapy*
  • Macular Edema / pathology
  • Macular Edema / virology
  • Male
  • West Nile Fever / complications*

Substances

  • Angiogenesis Inhibitors
  • Antibodies, Monoclonal, Humanized
  • Bevacizumab